Effect of pharmacologic treatments on the sleep of depressed patients.
Antidepressant drugs produce striking effects on sleep architecture that are best understood in terms of their interactions with the monoamine pathways controlling sleep and wakefulness. Many different antidepressant drugs, including tricyclic antidepressants (TCAs), monoamine oxidase inhibitors (MA...
Main Authors: | Sharpley, A, Cowen, P |
---|---|
Format: | Journal article |
Language: | English |
Published: |
1995
|
Similar Items
-
Olanzapine increases slow wave sleep and sleep continuity in SSRI-resistant depressed patients.
by: Sharpley, A, et al.
Published: (2005) -
Risperidone augmentation decreases rapid eye movement sleep and decreases wake in treatment-resistant depressed patients.
by: Sharpley, A, et al.
Published: (2003) -
Sleep and 5-HT2 receptor sensitivity in recovered depressed patients.
by: da Roza Davis, J, et al.
Published: (1992) -
Sleep stability with home sleep recording and automatic sleep stage analysis.
by: Sharpley, A, et al.
Published: (1990) -
Effect of nefazodone and lithium on sleep architecture in healthy men
by: Sharpley, A, et al.
Published: (1996)